Valuation: Ainos, Inc.

Market Cap 9.82M 8.72M 8.16M 7.39M 13.97M 947M 14.07M 97.99M 38.11M 483M 36.86M 36.07M 1.55B P/E 2024
-0.29x
P/E 2025 -0.47x
Enterprise Value 20.4M 18.11M 16.95M 15.36M 29.01M 1.97B 29.22M 204M 79.18M 1B 76.59M 74.94M 3.23B EV / Sales 2024
701x
EV / Sales 2025 162x
Free-Float
25.12%
Yield 2024 *
-
Yield 2025 -
1 day-3.01%
1 week+4.03%
Current month+1.57%
1 month-12.84%
3 months-36.76%
6 months-13.42%
Current year-21.34%
1 week 1.22
Extreme 1.22
1.4
1 month 1.2
Extreme 1.2
1.6
Current year 1.2
Extreme 1.2
3.88
1 year 1.2
Extreme 1.2
4.44
3 years 1.2
Extreme 1.2
21.45
5 years 1.2
Extreme 1.2
450
10 years 1.2
Extreme 1.2
1,781.25
Manager TitleAgeSince
Chief Executive Officer 56 2021-04-14
Director of Finance/CFO 54 2024-03-14
Director TitleAgeSince
Director/Board Member 49 2021-04-14
Director/Board Member 54 2021-04-14
Director/Board Member 42 2021-04-14
Date Insider Type Main position Quantity % Market Cap. Importance
6/3/26 Buy

Director

2,000 0.0286%
5/28/26 Buy

Director

250 0.0036%
5/27/26 Buy

Director

2,000 0.0286%
Change 5-day change 1-year change 3-year change Capi.($)
-3.01%+4.03%-66.58%-91.40% 9.82M
-2.98%-3.39%+20.71%+31.70% 250B
-2.53%-4.64%+1.84%-0.75% 156B
-0.42%-1.80%-9.99%+36.89% 144B
-0.50%-3.85%-56.37%-19.05% 61.45B
-0.86%-1.82%+12.96%+17.34% 50.28B
+1.66%-1.55%-20.09%-20.26% 46.73B
-1.00%-3.26%+19.57%+53.05% 48.29B
+0.02%+1.77%-5.42%+35.26% 45.89B
-0.84%-1.54%+33.21%+63.21% 43.24B
Average -0.82%-2.09%-7.02%+10.60% 84.52B
Weighted average by Cap. -1.23%-2.77%+2.86%+22.22%

Financials

2024 2025
Net sales 20.73K 18.4K 17.22K 15.61K 29.48K 2M 29.69K 207K 80.44K 1.02M 77.81K 76.14K 3.28M 124K 110K 103K 93.49K 177K 11.97M 178K 1.24M 482K 6.11M 466K 456K 19.63M
Net income -14.86M -13.19M -12.35M -11.19M -21.14M -1.43B -21.29M -148M -57.68M -731M -55.79M -54.59M -2.35B -14.77M -13.11M -12.27M -11.12M -21M -1.42B -21.16M -147M -57.32M -726M -55.44M -54.26M -2.34B
Net Debt 8.11M 7.2M 6.73M 6.1M 11.53M 782M 11.61M 80.89M 31.46M 399M 30.43M 29.78M 1.28B 10.58M 9.39M 8.79M 7.97M 15.05M 1.02B 15.16M 106M 41.07M 520M 39.72M 38.87M 1.67B
Projected Income Statement - Annual - Ainos, Inc.
Logo Ainos, Inc.
Ainos, Inc. is a dual-platform AI and biotech company advancing SmellTech and immune therapeutics. Its AI Nose platform and smell language model (SML) digitize scent into Smell ID, a machine-readable data, powering applications across robotics, smart factories, and healthcare. It is also developing VELDONA, an oral low-dose interferon therapy targeting rare diseases, autoimmune diseases, infectious diseases, and animal health. Its pipeline includes drug candidates for treating oral warts for human immunodeficiency virus seropositive patients, Sjogren’s syndrome, and feline chronic gingivostomatitis, a cat oral infection. Its product pipeline includes VELDONA Pet, VELDONA human drugs, AI Nose - NISD co-development, AI Nose industrial and robotics application, VOC POCT, VOC POCT Ainos Pen, VOC POCT CHS430, and Synthetic RNA (SRNA). VOC POCT-Ainos Pen is a device intended to be a cloud-connected, multipurpose, portable breath analyzer that is intended to monitor health conditions.
Employees
41
Date Price Change Volume
26-10-06 US$1.290 -3.01% 41,863
26-10-05 US$1.330 -1.70% 30,297
26-10-02 US$1.353 +4.08% 51,186
26-10-01 US$1.300 +2.36% 41,898
26-09-30 US$1.270 +2.42% 136,979
  1. Stock Market
  2. Stocks
  3. AIMD Stock